First Time Loading...

Standard BioTools Inc
NASDAQ:LAB

Watchlist Manager
Standard BioTools Inc Logo
Standard BioTools Inc
NASDAQ:LAB
Watchlist
Price: 2.465 USD -1.79%
Updated: May 6, 2024
LAB
/
Income Statement
/
Revenue

Standard BioTools Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Standard BioTools Inc
Revenue Peer Comparison

Comparables:
TMO
DHR
WST
A
IQV

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Standard BioTools Inc
NASDAQ:LAB
Revenue
$106.3m
CAGR 3-Years
-8%
CAGR 5-Years
-1%
CAGR 10-Years
4%
Thermo Fisher Scientific Inc
NYSE:TMO
Revenue
$42.9B
CAGR 3-Years
10%
CAGR 5-Years
12%
CAGR 10-Years
13%
Danaher Corp
NYSE:DHR
Revenue
$43.7B
CAGR 3-Years
21%
CAGR 5-Years
21%
CAGR 10-Years
9%
West Pharmaceutical Services Inc
NYSE:WST
Revenue
$2.9B
CAGR 3-Years
8%
CAGR 5-Years
11%
CAGR 10-Years
8%
Agilent Technologies Inc
NYSE:A
Revenue
$6.7B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
8%
IQVIA Holdings Inc
NYSE:IQV
Revenue
$15B
CAGR 3-Years
10%
CAGR 5-Years
8%
CAGR 10-Years
11%

Standard BioTools Inc
Revenue Breakdown

Breakdown by Geography
Standard BioTools Inc

Total Revenue: 106.3m USD
100%
Americas: 46.2m USD
43.4%
EMEA: 36.2m USD
34%
Asia Pacific: 23.9m USD
22.5%

Breakdown by Segments
Standard BioTools Inc

Total Revenue: 106.3m USD
100%
Product And Service: 105.2m USD
98.9%
Product: 79.2m USD
74.5%
Consumables: 41.7m USD
39.3%
Instruments: 37.5m USD
35.2%
Service: 26m USD
24.4%
Product And Service, Other: 1.2m USD
1.1%
Show More
Show Less

See Also

What is Standard BioTools Inc's Revenue?
Revenue
106.3m USD

Based on the financial report for Dec 31, 2023, Standard BioTools Inc's Revenue amounts to 106.3m USD.

What is Standard BioTools Inc's Revenue growth rate?
Revenue CAGR 10Y
4%

Over the last year, the Revenue growth was 9%. The average annual Revenue growth rates for Standard BioTools Inc have been -8% over the past three years , -1% over the past five years , and 4% over the past ten years .

ALPHA SPREAD
Join more than 134,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.